Studies with lung cancer, pancreatic cancer, and hepatocellular carcinoma cell lines showed that NRF2-KEAP1 status directly affects their proliferation rates since NRF2-negative cells proliferate slower, while KEAP1-deleted cells proliferate faster than their wild type counterparts [162,163,164]. This evidence concerns the gene KEAP1 and lung carcinoma.